Linda Boxer, MD, PhD

Hematologist, Multiple myeloma specialist

Vice Dean of the School of Medicine and Professor of Medicine (Hematology)

Hematology Program

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic Getting Here Make An Appointment

Professional Education

Fellowship: Stanford University School of Medicine (1990) CA

Fellowship: Stanford University School of Medicine (1989) CA

Residency: Stanford University School of Medicine (1984) CA

Internship: Stanford University School of Medicine (1982) CA

Board Certification: Medical Oncology, American Board of Internal Medicine (1987)

Board Certification: Internal Medicine, American Board of Internal Medicine (1984)

Medical Education: Stanford University School of Medicine (1981) CA

MD, Stanford University, Medicine (1981)

PhD, Stanford University, Biophysics (1981)

Administrative Appointments

Chief, Division of Hematology, Stanford University School of Medicine (2004 - Present)

Clinical interpretation and implications of whole-genome sequencing.
Dewey, F. E., Grove, M. E., Pan, C., Goldstein, B. A., Bernstein, J. A., & Quertermous, T. (2014). Clinical interpretation and implications of whole-genome sequencing. JAMA-the journal of the American Medical Association, 311(10), 1035-1045.

Clinical Interpretation and Implications of Whole-Genome Sequencing
Dewey, F. E., Grove, M. E., Pan, C., Goldstein, B. A., Bernstein, J. A., & Quertermous, T. (2014). Clinical Interpretation and Implications of Whole-Genome Sequencing. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 311(10), 1035-1044.

The immunoglobulin heavy chain gene 3 ' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells
Xiang, H., Noonan, E. J., Wang, J., Duan, H., Ma, L., & Boxer, L. M. (2011). The immunoglobulin heavy chain gene 3 ' enhancers induce Bcl2 deregulation and lymphomagenesis in murine B cells. LEUKEMIA, 25(9), 1484-1493.

Functional long-range interactions of the IgH 3 ' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells
Duan, H., Xiang, H., Ma, L., & Boxer, L. M. (2008). Functional long-range interactions of the IgH 3 ' enhancers with the bcl-2 promoter region in t(14;18) lymphoma cells. ONCOGENE, 27(53), 6720-6728.

Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability
Dhakshinamoorthy, S., Sridharan, S. R., Li, L., Ng, P. Y., Boxer, L. M., & Porter, A. G. (2007). Protein/DNA arrays identify nitric oxide-regulated cis-element and trans-factor activities some of which govern neuroblastoma cell viability. NUCLEIC ACIDS RESEARCH, 35(16), 5439-5451.

The immunoglobulin heavy-chain gene 3 ' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells
Duan, H., Heckman, C. A., & Boxer, L. M. (2007). The immunoglobulin heavy-chain gene 3 ' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells. ONCOGENE, 26(18), 2635-2641.

Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer
Hu, H.-M., Kanda, K., Zhang, L., & Boxer, L. M. (2007). Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer. LEUKEMIA, 21(4), 747-753.

Artificial zinc(II) complexes regulate cell cycle and apoptosis-related genes in tumor cell lines
Gao, J., Liu, Y.-G., Zhou, Y., Boxer, L. M., Woolley, F. R., & Zingaro, R. A. (2007). Artificial zinc(II) complexes regulate cell cycle and apoptosis-related genes in tumor cell lines. CHEMBIOCHEM, 8(3), 332-340.

Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells
Xiang, H., Wang, J., & Boxer, L. M. (2006). Role of the cyclic AMP response element in the bcl-2 promoter in the regulation of endogenous Bcl-2 expression and apoptosis in murine B cells. MOLECULAR AND CELLULAR BIOLOGY, 26(22), 8599-8606.

Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo.
Kobayashi, S., Lackey, T., Huang, Y., Bisping, E., Pu, W. T., & Liang, Q. (2006). Transcription factor gata4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB journal , 20(6), 800-802.

Transcription factor GATA4 regulates cardiac BCL2 gene expression in vitro and in vivo
Kobayashi, S., Lackey, T., Huang, Y., Bisping, E., Pu, W. T., & Liang, Q. (2006). Transcription factor GATA4 regulates cardiac BCL2 gene expression in vitro and in vivo. FASEB JOURNAL, 20(2), 800-?.

Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression
Heckman, C. A., Duan, H., Garcia, P. B., & Boxer, L. M. (2006). Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expression. ONCOGENE, 25(6), 888-898.

C/EBP alpha and C/EBP alpha myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with NF-kappa B p50.
Paz-Priel, I., Cai, D. H., Wang, D. H., Kowalski, J., Blackford, A., & Friedman, A. D. (2005). C/EBP alpha and C/EBP alpha myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with NF-kappa B p50. BLOOD, 106(11), 838A-839A.

CCAAT/enhancer binding protein alpha (C/EBP alpha) and C/EBP alpha myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with nuclear factor-kappa B p50
Paz-Priel, I., Cai, D. H., Wang, D. H., Kowalski, J., Blackford, A., & Friedman, A. D. (2005). CCAAT/enhancer binding protein alpha (C/EBP alpha) and C/EBP alpha myeloid oncoproteins induce Bcl-2 via interaction of their basic regions with nuclear factor-kappa B p50. MOLECULAR CANCER RESEARCH, 3(10), 585-596.

Regulatory elements in the immunoglobulin heavy chain gene 3 '-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells
Wang, J. H., & Boxer, L. M. (2005). Regulatory elements in the immunoglobulin heavy chain gene 3 '-enhancers induce c-myc deregulation and lymphomagenesis in murine B cells. JOURNAL OF BIOLOGICAL CHEMISTRY, 280(13), 12766-12773.

Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas
Duan, H., Heckman, C. A., & Boxer, L. M. (2005). Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. MOLECULAR AND CELLULAR BIOLOGY, 25(5), 1608-1619.

A genome-wide view of the in vitro response to L-asparaginase in acute lymphoblastic leukemia
Fine, B. M., Kaspers, G. Jl., Ho, M., Loonen, A. H., & Boxer, L. M. (2005). A genome-wide view of the in vitro response to L-asparaginase in acute lymphoblastic leukemia. CANCER RESEARCH, 65(1), 291-299.

C/EBP alpha and C/EBP alpha myeloid oncoproteins inhibit apoptosis and induce bcl-2 via DNA-binding dependent and independent mechanisms.
Paz-Priel, I., Cai, D. H., Wang, D. H., Heckman, C. A., Gombart, A. F., & Friedman, A. D. (2004). C/EBP alpha and C/EBP alpha myeloid oncoproteins inhibit apoptosis and induce bcl-2 via DNA-binding dependent and independent mechanisms. BLOOD, 104(11), 701A-702A.

Neurotrophin-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte progenitor cells
Saini, H. S., Gorse, K. M., Boxer, L. M., & Sato-Bigbee, C. (2004). Neurotrophin-3 and a CREB-mediated signaling pathway regulate Bcl-2 expression in oligodendrocyte progenitor cells. JOURNAL OF NEUROCHEMISTRY, 89(4), 951-961.

Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia
Fine, B. M., Stanulla, M., Schrappe, M., Ho, M., Viehmann, S., & Boxer, L. M. (2004). Gene expression patterns associated with recurrent chromosomal translocations in acute lymphoblastic leukemia. BLOOD, 103(3), 1043-1049.

Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2
Heckman, C. A., Cao, T., Somsouk, L., Duan, H., Mehew, J. W., & Boxer, L. M. (2003). Critical elements of the immunoglobulin heavy chain gene enhancers for deregulated expression of bcl-2. CANCER RESEARCH, 63(20), 6666-6673.

Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells
Heckman, C. A., Wheeler, M. A., & Boxer, L. M. (2003). Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells. ONCOGENE, 22(39), 7891-7899.

Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells
Jambal, P., Masterson, S., Nesterova, A., Bouchard, R., Bergman, B., & Pugazhenthi, S. (2003). Cytokine-mediated down-regulation of the transcription factor cAMP-response element-binding protein in pancreatic beta-cells. JOURNAL OF BIOLOGICAL CHEMISTRY, 278(25), 23055-23065.

Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons
Pugazhenthi, S., Nesterova, A., Jambal, P., Audesirk, G., Kern, M., & Reusch, J. Eb. (2003). Oxidative stress-mediated down-regulation of bcl-2 promoter in hippocampal neurons. JOURNAL OF NEUROCHEMISTRY, 84(5), 982-996.

Impaired proliferation and survival of activated B cells in transgenic mice that express a dominant-negative cAMP-response element-binding protein transcription factor in B cells
Zhang, C. Y., Wu, Y. L., & Boxer, L. M. (2002). Impaired proliferation and survival of activated B cells in transgenic mice that express a dominant-negative cAMP-response element-binding protein transcription factor in B cells. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(50), 48359-48365.

In childhood acute lymphoblastic leukemia, BCR/ABL is associated with a more heterogeneous pattern of gene expression than is TEL/AML1 or MLL/AF4.
Fine, B. M., Stanulla, M., Schrappe, M., Ho, M. T., HARBOTT, J., & Boxer, L. M. (2002). In childhood acute lymphoblastic leukemia, BCR/ABL is associated with a more heterogeneous pattern of gene expression than is TEL/AML1 or MLL/AF4. BLOOD, 100(11), 753A-753A.

NF-kappa B activates Bcl-2 expression in t(14;18) lymphoma cells
Heckman, C. A., Mehew, J. W., & Boxer, L. M. (2002). NF-kappa B activates Bcl-2 expression in t(14;18) lymphoma cells. ONCOGENE, 21(24), 3898-3908.

A myc-associated zinc finger protein-related factor binding site is required for the deregulation of c-myc expression by the immunoglobulin heavy chain gene enhancers in Burkitt's lymphoma
Hu, H. M., Arcinas, M., & Boxer, L. M. (2002). A myc-associated zinc finger protein-related factor binding site is required for the deregulation of c-myc expression by the immunoglobulin heavy chain gene enhancers in Burkitt's lymphoma. JOURNAL OF BIOLOGICAL CHEMISTRY, 277(12), 9819-9824.

Allele-specific analysis of transcription factors binding to promoter regions
Heckman, C. A., & Boxer, L. M. (2002). Allele-specific analysis of transcription factors binding to promoter regions. METHODS, 26(1), 19-26.

The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells
Li, C., Ahlborn, T. E., Tokita, K., Boxer, L. M., Noda, A., & Liu, J. W. (2001). The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells. ONCOGENE, 20(57), 8193-8202.

The mechanism of bcl-2 activation by NF-kappa B in t(14;18) lymphomas.
Heckman, C. A., Mehew, J. W., & Boxer, L. M. (2001). The mechanism of bcl-2 activation by NF-kappa B in t(14;18) lymphomas. BLOOD, 98(11), 760A-760A.

Translocations involving c-myc and c-myc function
Boxer, L. M., & DANG, C. V. (2001). Translocations involving c-myc and c-myc function. ONCOGENE, 20(40), 5595-5610.

The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells
Freeland, K., Boxer, L. M., & Latchman, D. S. (2001). The cyclic AMP response element in the Bcl-2 promoter confers inducibility by hypoxia in neuronal cells. MOLECULAR BRAIN RESEARCH, 92(1-2), 98-106.

Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma
Arcinas, M., Heckman, C. A., Mehew, J. W., & Boxer, L. M. (2001). Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphoma. CANCER RESEARCH, 61(13), 5202-5206.

Suppression of apoptosis and granulocyte colony-stimulating factor-induced differentiation by an oncogenic form of Cbl
Sinha, S., Jancarik, J., Roginskaya, V., Rothermund, K., Boxer, L. M., & Corey, S. J. (2001). Suppression of apoptosis and granulocyte colony-stimulating factor-induced differentiation by an oncogenic form of Cbl. EXPERIMENTAL HEMATOLOGY, 29(6), 746-755.

Negative regulation of bcl-2 expression by p53 in hematopoietic cells
Wu, Y. L., Mehew, J. W., Heckman, C. A., Arcinas, M., & Boxer, L. M. (2001). Negative regulation of bcl-2 expression by p53 in hematopoietic cells. ONCOGENE, 20(2), 240-251.

Nerve growth factor- and epidermal growth factor-regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells
Groot, M., Boxer, L. M., & Thiel, G. (2000). Nerve growth factor- and epidermal growth factor-regulated gene transcription in PC12 pheochromocytoma and INS-1 insulinoma cells. EUROPEAN JOURNAL OF CELL BIOLOGY, 79(12), 924-935.

Regulation of Bcl-2 expression by NF-kappa B in t(14;18) lymphoma cells.
Heckman, C. A., Mehew, J. W., & Boxer, L. M. (2000). Regulation of Bcl-2 expression by NF-kappa B in t(14;18) lymphoma cells. BLOOD, 96(11), 299A-299A.

NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer
Kanda, K., Hu, H. M., Zhang, L., Grandchamps, J., & Boxer, L. M. (2000). NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(41), 32338-32346.

Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein
Pugazhenthi, S., Nesterova, A., Sable, C., Heidenreich, K. A., Boxer, L. M., & Reusch, J. Eb. (2000). Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(15), 10761-10766.

A-Myb up-regulates bcl-2 through a Cdx binding site in t(14;18) lymphoma cells
Heckman, C. A., Mehew, J. W., Ying, G. G., Introna, M., Golay, J., & Boxer, L. M. (2000). A-Myb up-regulates bcl-2 through a Cdx binding site in t(14;18) lymphoma cells. JOURNAL OF BIOLOGICAL CHEMISTRY, 275(9), 6499-6508.

The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M
Liu, J. W., Li, C., Ahlborn, T. E., Spence, M. J., Meng, L., & Boxer, L. M. (1999). The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M. CELL GROWTH & DIFFERENTIATION, 10(10), 677-683.

Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein
Pugazhenthi, S., Millers, E., Sable, C., Young, P., Heidenreich, K. A., & Reusch, J. Eb. (1999). Insulin-like growth factor-I induces bcl-2 promoter through the transcription factor cAMP-response element-binding protein. JOURNAL OF BIOLOGICAL CHEMISTRY, 274(39), 27529-27535.

A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells
Chalaux, E., Lopez-Rovira, T., Rosa, J. L., Pons, G., Boxer, L. M., & Ventura, F. (1999). A zinc-finger transcription factor induced by TGF-beta promotes apoptotic cell death in epithelial Mv1Lu cells. FEBS LETTERS, 457(3), 478-482.

p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor
Budhram-Mahadeo, V., Morris, P. J., Smith, M. D., Midgley, C. A., Boxer, L. M., & Latchman, D. S. (1999). p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. JOURNAL OF BIOLOGICAL CHEMISTRY, 274(21), 15237-15244.

Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade
Liu, Y. Z., Boxer, L. M., & Latchman, D. S. (1999). Activation of the Bcl-2 promoter by nerve growth factor is mediated by the p42/p44 MAPK cascade. NUCLEIC ACIDS RESEARCH, 27(10), 2086-2090.

An NF-kappa B site in the IgH enhancer deregulates bcl-2 expression in t(14;18) lymphomas.
Somsouk, L., Heckman, C. A., Mehew, J. W., Kanda, K., & Boxer, L. M. (1999). An NF-kappa B site in the IgH enhancer deregulates bcl-2 expression in t(14;18) lymphomas. FASEB JOURNAL, 13(7), A1465-A1465.

An NF-kappa B site in the IgH enhancer deregulates c-myc expression in Burkitt's lymphoma.
Kanda, K., Grandchamps, J., & Boxer, L. M. (1998). An NF-kappa B site in the IgH enhancer deregulates c-myc expression in Burkitt's lymphoma. BLOOD, 92(10), 382A-382A.

The N-terminal domain unique to the long form of the Brn-3a transcription factor is essential to protect neuronal cells from apoptosis and for the activation of Bcl-2 gene expression
Smith, M. D., DAWSON, S. J., Boxer, L. M., & Latchman, D. S. (1998). The N-terminal domain unique to the long form of the Brn-3a transcription factor is essential to protect neuronal cells from apoptosis and for the activation of Bcl-2 gene expression. NUCLEIC ACIDS RESEARCH, 26(18), 4100-4107.

Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor
Smith, M. D., Ensor, E. A., Coffin, R. S., Boxer, L. M., & Latchman, D. S. (1998). Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor. JOURNAL OF BIOLOGICAL CHEMISTRY, 273(27), 16715-16722.

The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas
Heckman, C., Mochon, E., Arcinas, M., & Boxer, L. M. (1997). The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(31), 19609-19614.

Identification of the major positive regulators of c-myb expression in hematopoietic cells of different lineages
Sullivan, J., Feeley, B., GUERRA, J., & Boxer, L. M. (1997). Identification of the major positive regulators of c-myb expression in hematopoietic cells of different lineages. JOURNAL OF BIOLOGICAL CHEMISTRY, 272(3), 1943-1949.

Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis
Wilson, B. E., Mochon, E., & Boxer, L. M. (1996). Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. MOLECULAR AND CELLULAR BIOLOGY, 16(10), 5546-5556.

CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas
Ji, L., Mochon, E., Arcinas, M., & Boxer, L. M. (1996). CREB proteins function as positive regulators of the translocated bcl-2 allele in t(14;18) lymphomas. JOURNAL OF BIOLOGICAL CHEMISTRY, 271(37), 22687-22691.

Identification of an inducible regulator of c-myb expression during T-cell activation
Phan, S. C., Feeley, B., Withers, D., & Boxer, L. M. (1996). Identification of an inducible regulator of c-myb expression during T-cell activation. MOLECULAR AND CELLULAR BIOLOGY, 16(5), 2387-2393.

REPRESSION OF THE C-MYB GENE BY WT1 PROTEIN IN T-CELL AND B-CELL LINES
McCann, S., Sullivan, J., GUERRA, J., Arcinas, M., & Boxer, L. M. (1995). REPRESSION OF THE C-MYB GENE BY WT1 PROTEIN IN T-CELL AND B-CELL LINES. JOURNAL OF BIOLOGICAL CHEMISTRY, 270(40), 23785-23789.

MYB BINDING-SITES MEDIATE NEGATIVE REGULATION OF C-MYB EXPRESSION IN T-CELL LINES
GUERRA, J., Withers, D. A., & Boxer, L. M. (1995). MYB BINDING-SITES MEDIATE NEGATIVE REGULATION OF C-MYB EXPRESSION IN T-CELL LINES. BLOOD, 86(5), 1873-1880.

PI-1 BINDING-SITES ARE NEGATIVE REGULATORS OF BCL-2 EXPRESSION IN PRE-B CELLS
Chen, H. M., & Boxer, L. M. (1995). PI-1 BINDING-SITES ARE NEGATIVE REGULATORS OF BCL-2 EXPRESSION IN PRE-B CELLS. MOLECULAR AND CELLULAR BIOLOGY, 15(7), 3840-3847.

THE TRANSCRIPTION FACTOR, NM23H2, BINDS TO AND ACTIVATES THE TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA
Ji, L., Arcinas, M., & Boxer, L. M. (1995). THE TRANSCRIPTION FACTOR, NM23H2, BINDS TO AND ACTIVATES THE TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA. JOURNAL OF BIOLOGICAL CHEMISTRY, 270(22), 13392-13398.

NF-KAPPA-B SITES FUNCTION AS POSITIVE REGULATORS OF EXPRESSION OF THE TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA
Ji, L., Arcinas, M., & Boxer, L. M. (1994). NF-KAPPA-B SITES FUNCTION AS POSITIVE REGULATORS OF EXPRESSION OF THE TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA. MOLECULAR AND CELLULAR BIOLOGY, 14(12), 7967-7974.

NF-KAPPA-B SITES FUNCTION AS POSITIVE REGULATORS OF EXPRESSION OF THE TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA
Ji, L., Arcinas, M., & Boxer, L. M. (1994). NF-KAPPA-B SITES FUNCTION AS POSITIVE REGULATORS OF EXPRESSION OF THE TRANSLOCATED C-MYC ALLELE IN BURKITTS-LYMPHOMA. BLOOD, 84(10), A37-A37.

DIFFERENTIAL PROTEIN-BINDING TO THE C-MYC PROMOTER DURING DIFFERENTIATION OF HEMATOPOIETIC-CELL LINES
Arcinas, M., & Boxer, L. M. (1994). DIFFERENTIAL PROTEIN-BINDING TO THE C-MYC PROMOTER DURING DIFFERENTIATION OF HEMATOPOIETIC-CELL LINES. ONCOGENE, 9(9), 2699-2706.

ACTIVATION OF C-MYC EXPRESSION BY C-ABL IS INDEPENDENT OF BOTH THE DNA-BINDING FUNCTION OF C-ABL AND THE C-MYC EP SITE
Arcinas, M., Sizer, K. C., & Boxer, L. M. (1994). ACTIVATION OF C-MYC EXPRESSION BY C-ABL IS INDEPENDENT OF BOTH THE DNA-BINDING FUNCTION OF C-ABL AND THE C-MYC EP SITE. JOURNAL OF BIOLOGICAL CHEMISTRY, 269(34), 21919-21924.

THE ROLE OF ONCOGENES IN HEMATOLOGIC MALIGNANCIES
Boxer, L. M. (1994). THE ROLE OF ONCOGENES IN HEMATOLOGIC MALIGNANCIES. ANNUAL REVIEW OF MEDICINE, 45, 1-11.